{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-048186","form_type":"8-K","ticker":"HSCS","cik":"0001468492","company_name":"HeartSciences Inc.","filed_at":"2023-09-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.013624+00:00","generated_at":"2026-06-10T17:31:44.125697+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"HeartSciences Q1 FY2024: no revenue, $576K cash; MyoVista FDA submission targeted for late 2023","bullets":["No revenue for Q1 FY2024; cash and equivalents of $576K as of July 31, 2023.","Completed enrollment for MyoVista pivotal study; targeting FDA submission in late 2023.","Expanded IP portfolio to 41 patents (9 US, 32 international); appointed new distributors in Nordic and India.","Secured $15M equity line (March 2023) and $1M promissory note (Sept 2023) for funding."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-048186","json":"https://secwatch.observer/filing/0000950170-23-048186.json","markdown":"https://secwatch.observer/filing/0000950170-23-048186.md","text":"https://secwatch.observer/filing/0000950170-23-048186.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468492/000095017023048186/0000950170-23-048186-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468492/000095017023048186/hscs-20230914.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T17:31:44.125697+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4688a2ca5cb947ab5b143389d941c5055acf6640","claim":"HeartSciences Inc. reported the first quarter fiscal 2024 ended July 31, 2023 results: revenue There were no revenues.","evidence_excerpt":"HeartSciences Reports First Quarter Fiscal 2024 Financial Results","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468492/000095017023048186/0000950170-23-048186-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter fiscal 2024 ended July 31, 2023"},{"label":"Revenue","value":"There were no revenues"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}